Protective effects of Schisandrin on high glucose-induced changes of RhoA and eNOS activity in human umbilical vein endothelial cells
| Autor: | Rong-Jin Zhang, Yong-Mei Hao, Qing-Juan Liu, Hui-Yao Hao, Hong-Ye Zuo, Zhong-Ji Zhi, Ying-Na Chang, Peng-Peng Guo |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
0301 basic medicine
RHOA Nitric Oxide Synthase Type III Schisandra chinensis Stimulation Pharmacology Schisandrin Umbilical vein Lignans Pathology and Forensic Medicine 03 medical and health sciences Cyclooctanes Enos Human Umbilical Vein Endothelial Cells Humans Secretion Polycyclic Compounds Rho-associated protein kinase biology Chemistry Cell Biology biology.organism_classification 030104 developmental biology Glucose biology.protein rhoA GTP-Binding Protein |
| Zdroj: | Pathology, research and practice. 214(9) |
| ISSN: | 1618-0631 |
| Popis: | Schisandrin, derived from the Chinese medicinal herb Schisandra chinensis, has been found to confer protective effects on circulation systems. But the underlying molecular mechanisms remain unclear. The aim of this study was to investigate the effects of a high level of glucose on RhoA and eNOS activity in human umbilical vein endothelial cells(HUVECs) and how Schisandrin plays a role in mediating these effects. To find the optimal treatment time, HUVECs were cultured at a high glucose concentration (30 mM) for different lengths of time (0, 12, 24, and 48 h). Subsequently, the cells were randomized into five groups: a normal group, a high glucose group, and three high glucose groups that were given different doses (5, 10, and 20 μM) of Schisandrin. The cells were pretreated with Schisandrin for 24 h before stimulation with high glucose. The morphology of HUVECs in the various groups was assessed under a light microscope. Immunocytochemical staining was used to detect the level of p-MYPT1 expression. The levels of RhoA activity were determined using the RhoA Activation Assay Biochem Kit. The levels of eNOS activity were examined using a nitrate reduction test. The results showed that in the high glucose group, the activity of RhoA was increased and the activity of eNOS was reduced, thus decreasing the secretion of NO. However, after pretreatment with Schisandrin (10, 20 μM), the activity of RhoA was inhibited and the activity of eNOS increased, which led to an increase in NO production compared with the high glucose group. There was no evident difference between the 5 μM Schisandrin group and the high glucose group. Taken together, these findings indicate that Schisandrin can improve the function of endothelial cells by lowering the activity of RhoA/Rho kinase and raising both the activity of eNOS and the production of NO. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect